February 18, 2010 USA
Marketwire.com: Vaccine for Diabetes Possible This Decade, Says Report
"... There are at least seven diabetes vaccine candidates in development. Most are in Phase I testing and address type 1 diabetes. But one being developed by the Swedish company Diamyd Medical is currently in a global Phase III trial, which includes 640 children and adolescents newly diagnosed with type 1 diabetes. The purpose of the Phase III trial is to confirm and evaluate the ability of the Diamyd vaccine to arrest or slow the autoimmune destruction of the body's insulin-producing cells, thereby preserving the body's own ability to produce insulin... "
Read the article here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.